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Introduction
Bone tumours are relatively rare in comparison with tumours in other parts of the body [1, 2] . Figures from the United States show an annual incidence of 2,100 cases of bone sarcoma. Considerable higher numbers were noted for lung cancer (93,000) and breast cancer (88,000) [1] [2] [3] [4] . The precise incidence of primary bone tumours and tumour-like lesions is not known because many benign bone lesions are not biopsied for histopathological analysis [4] .
These tumours present a challenge to the pathologist as well as the Orthopaedic surgeon. This challenge is magnified in an environment where resources are scarce. Late presentation also worsens outcomes and this is influenced by social, religious and other traditional beliefs among the population [5] . Bone tumours and tumour-like lesions have been found to occur mainly between the first and fourth decades of life. It is therefore clear that these tumours have a potentially devastating effect on the most productive segment of the population [6] . Oyemade et al and Omololu et al in their studies showed the possibility of geographical variations in the relative incidence of various histological types of bone tumours and their distributions according to age [7, 8] .
Osteosarcomas have been found to peak in two age groups in England and Wales. The first peak occurs between the first and second decades of life coinciding with the pubertal growth spurt, while the second peak occurs after the fourth decade. However, such a second peak was not found in the studies done in Nigeria.
This observation agrees with those made in Japan, the United States and Scandinavian countries and it has been attributed to a rarity of Paget's disease of the bone [7] [8] [9] . Mohammed et al in a 10 year retrospective review carried out in Zaria, Nigeria studied 127 patients with bone neoplasms. This number was 1.9% of the total 6,687 neoplasms reviewed during the period. Of those with bone neoplasms, 38.6% were benign tumours and 39.4% were malignant primary bone tumours. 22% were tumour-like lesions [10] . Obalum et al did a 25 year review of bone tumours in a tertiary health institution in Lagos, Nigeria and he found an annual average of about 100 cases. The most common benign and malignant tumours were osteochondroma and osteosarcoma respectively [6] . Variations have also been noted in the morphological distribution of these tumours. Earlier studies done in Nigeria have shown a high incidence of Burkitt lymphoma and a rarity of Ewing sarcoma, while studies in the United States and Asian countries showed the opposite [7, 8, 11] . No study has been carried out within the locality of Ile-Ife on this subject hence the current thirteen year retrospective study. The aim is to determine the various histological types and relative frequencies of primary bone tumours seen in 
Results
A total of 6,464 cases of neoplastic conditions were diagnosed during the period of study. Of these, 2481 (38.4%) were benign and 3983 (61.6%) were malignant. 100 cases (1.55% of all cases seen) were selected for this study of which 57 were males and 43
were females giving a male to female ratio of 1.3:1 (Table 1) . The average annual incidence of primary bone tumours during this period was 7.7%. Fifty cases (50%) were primary malignant bone tumours and the age range was 8 to 76 years with a mean age of 35.4 years and a peak incidence in the second decade of life. A summary of the age distribution of the various histological types of primary bone tumours and tumour-like lesions is shown in Table 2 .
Osteosarcoma was the most common primary malignant bone tumour seen, 21 cases (42%). The mean age for osteosarcomas
Page number not for citation purposes 3 was 21.33 years and majority (76.2%) were seen in the second and third decades of life. Nine cases occurred in the distal third of the femur (42.86%), three in the distal tibia (14.28%), three in the proximal tibia (14.28%), two in the mandible (9.52%) and one case each in the proximal third of the femur, the maxilla, humerus and calcaneus (4.76% each) as shown in Table 3 . Twenty eight cases (28%) were benign and the age range was 4 to 60 years. Peak incidence was in the 3rd decade of life. Osteochondroma was the most common benign tumour seen and accounted for 32.1% of all benign bone tumours (9 cases). The tibia was the commonest site, contributing 33.3% of all cases (3 cases). Twenty two cases (22%)
were tumour-like conditions. The age range was 9 to 65 years with a mean age of 31.5 years. Peak incidence was in the 2 nd and 3 rd decades of life (72.7%). The commonest site for tumour-like lesions was the maxilla as seen in 11 cases (50%) and the most frequent variant was fibrous dysplasia with 8 cases (36.4%). of all cancers [7] . This figure is however lower than that reported by cases (36.6%) out of 191 cases of benign tumours were seen in the third decade of life. The third decade peak was also true for tumour-like lesions in this present study. However, the study by Solomon in South Africa showed a 2 nd decade incidence peak for benign tumours and tumour like lesions [19] . The most frequently involved bone in primary malignant bone tumours, in this study, was the femur, which was involved in 12 cases (24%). This finding was consistent with that of Solomon in South Africa and Ahmad et al in Pakistan [18, 19] . They both reported femur as the most frequently involved bone in primary malignant tumours. However, Omololu et al at Ibadan reported that the mandible was the most frequently involved bone in primary bone cancer, followed by the femur, tibia and maxilla in decreasing order [8] . For tumour-like lesions, the maxilla and the mandible were the most frequently involved. This is similar to report by Umar in Zaria, which showed that the mandible and the maxilla were also more affected by tumour-like lesions [20] .
Discussion
The relative ratio frequencies of various histological types of primary [8] . The figure of 28.8%
reported for Sweden is significantly lower than 42% in this study.
There was a preponderance of Osteosarcoma in males with a male to female ratio of 1.  We recognize the fact that the data is not very current however we the authors feel the need to publish these findings for future reference.
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